These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25638532)

  • 21. Pattern of structural and functional brain abnormalities in asymptomatic granulin mutation carriers.
    Pievani M; Paternicò D; Benussi L; Binetti G; Orlandini A; Cobelli M; Magnaldi S; Ghidoni R; Frisoni GB
    Alzheimers Dement; 2014 Oct; 10(5 Suppl):S354-S363.e1. PubMed ID: 24418059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence that Abeta42 plasma levels in presenilin-1 mutation carriers do not allow for prediction of their clinical phenotype.
    De Jonghe C; Cras P; Vanderstichele H; Cruts M; Vanderhoeven I; Smouts I; Vanmechelen E; Martin JJ; Hendriks L; Van Broeckhoven C
    Neurobiol Dis; 1999 Aug; 6(4):280-7. PubMed ID: 10448055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypic profile of early-onset familial Alzheimer's disease caused by presenilin-1 E280A mutation.
    Sepulveda-Falla D; Glatzel M; Lopera F
    J Alzheimers Dis; 2012; 32(1):1-12. PubMed ID: 22766738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ERP generator anomalies in presymptomatic carriers of the Alzheimer's disease E280A PS-1 mutation.
    Bobes MA; García YF; Lopera F; Quiroz YT; Galán L; Vega M; Trujillo N; Valdes-Sosa M; Valdes-Sosa P
    Hum Brain Mapp; 2010 Feb; 31(2):247-65. PubMed ID: 19650138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry.
    Teipel SJ; Alexander GE; Schapiro MB; Möller HJ; Rapoport SI; Hampel H
    Brain; 2004 Apr; 127(Pt 4):811-24. PubMed ID: 14985261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful Scene Encoding in Presymptomatic Early-Onset Alzheimer's Disease.
    Quiroz YT; Willment KC; Castrillon G; Muniz M; Lopera F; Budson A; Stern CE
    J Alzheimers Dis; 2015; 47(4):955-64. PubMed ID: 26401774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel PSEN1 gene mutation (L235R) associated with familial early-onset Alzheimer's disease.
    Antonell A; Balasa M; Oliva R; Lladó A; Bosch B; Fabregat N; Fortea J; Molinuevo JL; Sánchez-Valle R
    Neurosci Lett; 2011 May; 496(1):40-2. PubMed ID: 21501661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pattern of atrophy in familial Alzheimer disease: volumetric MRI results from the DIAN study.
    Cash DM; Ridgway GR; Liang Y; Ryan NS; Kinnunen KM; Yeatman T; Malone IB; Benzinger TL; Jack CR; Thompson PM; Ghetti BF; Saykin AJ; Masters CL; Ringman JM; Salloway SP; Schofield PR; Sperling RA; Cairns NJ; Marcus DS; Xiong C; Bateman RJ; Morris JC; Rossor MN; Ourselin S; Fox NC;
    Neurology; 2013 Oct; 81(16):1425-33. PubMed ID: 24049139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrospinal fluid biomarkers in Alzheimer's disease families with PSEN1 mutations.
    Fortea J; Lladó A; Bosch B; Antonell A; Oliva R; Molinuevo JL; Sánchez-Valle R
    Neurodegener Dis; 2011; 8(4):202-7. PubMed ID: 21212633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disease-related cortical thinning in presymptomatic granulin mutation carriers.
    Borrego-Écija S; Sala-Llonch R; van Swieten J; Borroni B; Moreno F; Masellis M; Tartaglia C; Graff C; Galimberti D; Laforce R; Rowe JB; Finger E; Vandenberghe R; Tagliavini F; de Mendonça A; Santana I; Synofzik M; Ducharme S; Levin J; Danek A; Gerhard A; Otto M; Butler C; Frisoni G; Sorbi S; Heller C; Bocchetta M; Cash DM; Convery RS; Moore KM; Rohrer JD; Sanchez-Valle R;
    Neuroimage Clin; 2021; 29():102540. PubMed ID: 33418170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A longitudinal study of brain atrophy over two years in community-dwelling older individuals.
    Jiang J; Sachdev P; Lipnicki DM; Zhang H; Liu T; Zhu W; Suo C; Zhuang L; Crawford J; Reppermund S; Trollor J; Brodaty H; Wen W
    Neuroimage; 2014 Feb; 86():203-11. PubMed ID: 23959201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical phenotype of G206D mutation in the presenilin 1 gene in pathologically confirmed familial Alzheimer's disease.
    Wu YY; Cheng IH; Lee CC; Chiu MJ; Lee MJ; Chen TF; Hsu JL
    J Alzheimers Dis; 2011; 25(1):145-50. PubMed ID: 21335660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural and functional brain connectivity in presymptomatic familial frontotemporal dementia.
    Dopper EG; Rombouts SA; Jiskoot LC; den Heijer T; de Graaf JR; de Koning I; Hammerschlag AR; Seelaar H; Seeley WW; Veer IM; van Buchem MA; Rizzu P; van Swieten JC
    Neurology; 2014 Jul; 83(2):e19-26. PubMed ID: 25002573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal changes in resting state networks in early presymptomatic carriers of C9orf72 expansions.
    Shoukry RS; Waugh R; Bartlett D; Raitcheva D; Floeter MK
    Neuroimage Clin; 2020; 28():102354. PubMed ID: 32769055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A patient with posterior cortical atrophy possesses a novel mutation in the presenilin 1 gene.
    Sitek EJ; Narożańska E; Pepłońska B; Filipek S; Barczak A; Styczyńska M; Mlynarczyk K; Brockhuis B; Portelius E; Religa D; Barcikowska M; Sławek J; Żekanowski C
    PLoS One; 2013; 8(4):e61074. PubMed ID: 23593396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early structural changes in individuals at risk of familial Alzheimer's disease: a volumetry and magnetization transfer MR imaging study.
    Ginestroni A; Battaglini M; Della Nave R; Moretti M; Tessa C; Giannelli M; Caffarra P; Nacmias B; Bessi V; Sorbi S; Bracco L; De Stefano N; Mascalchi M
    J Neurol; 2009 Jun; 256(6):925-32. PubMed ID: 19252791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cortical and hippocampal atrophy in patients with autosomal dominant familial Alzheimer's disease.
    Apostolova LG; Hwang KS; Medina LD; Green AE; Braskie MN; Dutton RA; Lai J; Geschwind DH; Cummings JL; Thompson PM; Ringman JM
    Dement Geriatr Cogn Disord; 2011; 32(2):118-25. PubMed ID: 21952501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cortical thickness in untreated transsexuals.
    Zubiaurre-Elorza L; Junque C; Gómez-Gil E; Segovia S; Carrillo B; Rametti G; Guillamon A
    Cereb Cortex; 2013 Dec; 23(12):2855-62. PubMed ID: 22941717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease.
    Doré V; Villemagne VL; Bourgeat P; Fripp J; Acosta O; Chetélat G; Zhou L; Martins R; Ellis KA; Masters CL; Ames D; Salvado O; Rowe CC
    JAMA Neurol; 2013 Jul; 70(7):903-11. PubMed ID: 23712469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers.
    Chételat G; Fouquet M
    Rev Neurol (Paris); 2013 Oct; 169(10):729-36. PubMed ID: 24016463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.